Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CEBIOTEX logo — Providing solutions for patients with cancer by helping surg...

CEBIOTEX

Providing solutions for patients with cancer by helping surgeons in their oncological interventions.

Founded 2015 Spain Spain 8 employees Equity Crowdfunding Total: $3.58M Biotechnology, Health Care +2

General Information

Company Name CEBIOTEX
Founded Year 2015
Location Spain Spain +1
Founders / Decision Makers
Team member
Employees 8
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Equity Crowdfunding
Social

Get notified when CEBIOTEX moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CEBIOTEX

CEBIOTEX is a biotechnology startup based in Spain that aims to provide solutions for cancer patients by aiding surgeons in their oncological interventions. The company utilizes nanofiber engineering to develop a medical product that can be infused with multiple agents, particularly beneficial for low water solubility drugs. CEBIOTEX's proprietary technology enables the production of biocompatible-biodegradable membranes protected by several patents in EU, USA, and China. Their primary focus is on addressing the medical need in oncology by enhancing local control of cancer after surgery to reduce recurrence and spreading of tumor cells. Their first product, CEB-01, incorporates a nanofiber membrane and the chemotherapy drug SN-38. Notably, it has received Orphan Drug Designation (ODD) in the EU for Soft Tissue Sarcoma (STS). CEB-01 is designed to be placed over the surgical bed immediately after tumor removal, delivering SN-38 locally during the postoperative period when no other therapy can be administered. The company has achieved significant milestones, including the completion of preclinical work, GMP certification for manufacturing, and regulatory approvals to initiate clinical trials at Hospital de Sant Pau in Barcelona, which have shown promising results. Founded in 2012, CEBIOTEX began as a spin-off of UPC and Hospital Sant Joan de Déu de Barcelona. The startup recently secured a €750.00K equity crowdfunding investment at 23 December 2020, reflecting investor confidence in the company's innovative approach to addressing critical medical needs in cancer treatment. The intersection of biotechnology, healthcare, and manufacturing underscores its potential for disrupting the oncology space and improving patient outcomes.

Taxonomy: Cancer treatment, Nanofiber engineering, Medical product development, Drug delivery technology, Oncology, Chemotherapy innovation, Surgical oncology, Orphan drug designation, Clinical trials, Biomedical technology, Biodegradable membranes, GMP certification, Hospital partnerships, Spin-off company, Preclinical research

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Equity Crowdfunding •••••• - 23 Dec 2020
Equity Crowdfunding •••••• 1 •••• •••• 08 Jan 2018
Series A •••••• 5
Investor Investor
•••• •••• 		16 Feb 2017
Grant •••••• 1 •••• •••• 01 Feb 2017
Seed Round •••••• 1
Investor
15 Dec 2016

View All 6 Funding Rounds

FAQ About CEBIOTEX

Providing solutions for patients with cancer by helping surgeons in their oncological interventions.
CEBIOTEX was founded in 2015.
CEBIOTEX is headquartered in Spain.
CEBIOTEX operates in the following industries: Biotechnology, Health Care, Life Sciences, Manufacturing.
CEBIOTEX has approximately 8 employees.
CEBIOTEX has completed 6 funding rounds, raising a total of $3.58M. The latest funding stage is Equity Crowdfunding.

We're actively collecting intelligence on CEBIOTEX.

Track CEBIOTEX to get notified

Don't just browse. Track.

Signal Tracker monitors CEBIOTEX and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes